These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 8178462

  • 21. High cell surface expression of Newcastle disease virus proteins via replicon vectors demonstrates syncytia forming activity of F and fusion promotion activity of HN molecules.
    Zeng J, Fournier P, Schirrmacher V.
    Int J Oncol; 2004 Aug; 25(2):293-302. PubMed ID: 15254725
    [Abstract] [Full Text] [Related]

  • 22. Antigenic analysis of chimeric and truncated G proteins of respiratory syncytial virus.
    Sullender W.
    Virology; 1995 May 10; 209(1):70-9. PubMed ID: 7747486
    [Abstract] [Full Text] [Related]

  • 23. Chimeric subgroup A respiratory syncytial virus with the glycoproteins substituted by those of subgroup B and RSV without the M2-2 gene are attenuated in African green monkeys.
    Cheng X, Zhou H, Tang RS, Munoz MG, Jin H.
    Virology; 2001 Apr 25; 283(1):59-68. PubMed ID: 11312662
    [Abstract] [Full Text] [Related]

  • 24. Identification of viral membrane proteins required for cell fusion and viral dissemination that are modified during vaccinia virus persistence.
    Ortiz MA, Paez E.
    Virology; 1994 Jan 25; 198(1):155-68. PubMed ID: 8259650
    [Abstract] [Full Text] [Related]

  • 25. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
    Li X, Sambhara S, Li CX, Ettorre L, Switzer I, Cates G, James O, Parrington M, Oomen R, Du RP, Klein M.
    Virology; 2000 Mar 30; 269(1):54-65. PubMed ID: 10725198
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Evaluation in non-human primates of the safety, immunogenicity and efficacy of recombinant vaccinia viruses expressing the F or G glycoprotein of respiratory syncytial virus.
    Olmsted RA, Buller RM, Collins PL, London WT, Beeler JA, Prince GA, Chanock RM, Murphy BR.
    Vaccine; 1988 Dec 30; 6(6):519-24. PubMed ID: 3072795
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment glycoprotein gene.
    Techaarpornkul S, Barretto N, Peeples ME.
    J Virol; 2001 Aug 30; 75(15):6825-34. PubMed ID: 11435561
    [Abstract] [Full Text] [Related]

  • 30. Paramyxovirus mediated cell fusion requires co-expression of both the fusion and hemagglutinin-neuraminidase glycoproteins.
    Heminway BR, Yu Y, Galinski MS.
    Virus Res; 1994 Jan 30; 31(1):1-16. PubMed ID: 8165862
    [Abstract] [Full Text] [Related]

  • 31. Definition and functional analysis of the signal/anchor domain of the human respiratory syncytial virus glycoprotein G.
    Lichtenstein DL, Roberts SR, Wertz GW, Ball LA.
    J Gen Virol; 1996 Jan 30; 77 ( Pt 1)():109-18. PubMed ID: 8558117
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Insertion of the two cleavage sites of the respiratory syncytial virus fusion protein in Sendai virus fusion protein leads to enhanced cell-cell fusion and a decreased dependency on the HN attachment protein for activity.
    Rawling J, García-Barreno B, Melero JA.
    J Virol; 2008 Jun 30; 82(12):5986-98. PubMed ID: 18385247
    [Abstract] [Full Text] [Related]

  • 34. Leucine at position 383 of fusion protein is responsible for fusogenicity of wild-type mumps virus in B95a cells.
    Yoshida N, Nakayama T.
    Intervirology; 2010 Jun 30; 53(4):193-202. PubMed ID: 20332648
    [Abstract] [Full Text] [Related]

  • 35. Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion.
    González-Reyes L, Ruiz-Argüello MB, García-Barreno B, Calder L, López JA, Albar JP, Skehel JJ, Wiley DC, Melero JA.
    Proc Natl Acad Sci U S A; 2001 Aug 14; 98(17):9859-64. PubMed ID: 11493675
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Evidence for the role of glycoprotein G of respiratory syncytial virus in binding of Neisseria meningitidis to HEp-2 cells.
    Raza MW, Blackwell CC, Ogilvie MM, Saadi AT, Stewart J, Elton RA, Weir DM.
    FEMS Immunol Med Microbiol; 1994 Nov 14; 10(1):25-30. PubMed ID: 7874075
    [Abstract] [Full Text] [Related]

  • 38. Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse.
    Bukreyev A, Whitehead SS, Murphy BR, Collins PL.
    J Virol; 1997 Dec 14; 71(12):8973-82. PubMed ID: 9371553
    [Abstract] [Full Text] [Related]

  • 39. Recombinant Sendai viruses expressing fusion proteins with two furin cleavage sites mimic the syncytial and receptor-independent infection properties of respiratory syncytial virus.
    Rawling J, Cano O, Garcin D, Kolakofsky D, Melero JA.
    J Virol; 2011 Mar 14; 85(6):2771-80. PubMed ID: 21228237
    [Abstract] [Full Text] [Related]

  • 40. The role of N-glycosylation in cell fusion induced by a vaccinia recombinant virus expressing both measles virus glycoproteins.
    Malvoisin E, Wild F.
    Virology; 1994 Apr 14; 200(1):11-20. PubMed ID: 8128615
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.